» Articles » PMID: 1427977

Interleukin-1 Receptor Antagonist in Inflammatory Exudate Cells of Rabbits. Production, Purification and Determination of Primary Structure

Overview
Journal Immunology
Date 1992 Oct 1
PMID 1427977
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

A rabbit interleukin-1 (IL-1) inhibitor in inflammatory peritoneal exudate cells was purified to apparent homogeneity. This inhibitor was extracted from exudate cells of the 24-hr stage of casein-induced peritoneal inflammation and purified using isoelectrofocusing (IEF), gel filtration, followed in this order by high-performance liquid chromatography (HPLC) steps with hydroxylapatite and anionic ion exchanger. The purified factor showed a single band on silver-stained SDS-PAGE. This molecule of MW 19,000 and pI 5.5 inhibited the binding of both IL-1 alpha and beta to receptors on a thymoma cell line, EL-4 and a B-cell line, 70Z/3. We determined its primary structure by a combination of peptide chemistry and molecular cloning. The inhibitor was synthesized as a precursor composed of 177 amino acids and was processed to a mature molecule of 143 amino acids. The N-terminal amino acid of the mature inhibitor was N-acetyl-methionine residue. The deduced amino acid sequence of the inhibitor showed a 77% homology to the human IL-1 receptor antagonist (IL-1Ra) and essentially the same mode of action as seen with human IL-1Ra. We consider that this inhibitor is a rabbit counterpart of human IL-1Ra, although there are differences with respect to the molecular structure; the N-terminus of the mature rabbit IL-1Ra at a position of nine amino acids downstream from that of human IL-1Ra.

Citing Articles

Administration of neutralizing antibody against rabbit IL-1 receptor antagonist exacerbates lipopolysaccharide-induced arthritis in rabbits.

Fukumoto T, Matsukawa A, Ohkawara S, Takagi K, Yoshinaga M Inflamm Res. 1996; 45(9):479-85.

PMID: 8891760 DOI: 10.1007/BF02252320.


Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB).

Kadota J, Matsubara Y, Ishimatsu Y, Ashida M, Abe K, Shirai R Clin Exp Immunol. 1996; 103(3):461-6.

PMID: 8608647 PMC: 2200364. DOI: 10.1111/j.1365-2249.1996.tb08303.x.


Production of IL-1 and IL-1 receptor antagonist and the pathological significance in lipopolysaccharide-induced arthritis in rabbits.

Matsukawa A, Ohkawara S, Maeda T, Takagi K, Yoshinaga M Clin Exp Immunol. 1993; 93(2):206-11.

PMID: 8348745 PMC: 1554844. DOI: 10.1111/j.1365-2249.1993.tb07967.x.


Role of interleukin-1 in the pathogenesis of experimental shigellosis.

Sansonetti P, Arondel J, Cavaillon J, Huerre M J Clin Invest. 1995; 96(2):884-92.

PMID: 7635983 PMC: 185275. DOI: 10.1172/JCI118135.

References
1.
Barrett A, Kembhavi A, Brown M, KIRSCHKE H, Knight C, Tamai M . L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem J. 1982; 201(1):189-98. PMC: 1163625. DOI: 10.1042/bj2010189. View

2.
Bidlingmeyer B, Cohen S, Tarvin T . Rapid analysis of amino acids using pre-column derivatization. J Chromatogr. 1984; 336(1):93-104. DOI: 10.1016/s0378-4347(00)85133-6. View

3.
Granowitz E, Clark B, Mancilla J, Dinarello C . Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor. J Biol Chem. 1991; 266(22):14147-50. View

4.
McMahan C, Slack J, Mosley B, Cosman D, Lupton S, Brunton L . A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. EMBO J. 1991; 10(10):2821-32. PMC: 452992. DOI: 10.1002/j.1460-2075.1991.tb07831.x. View

5.
Eisenberg S, Evans R, Arend W, VERDERBER E, Brewer M, Hannum C . Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist. Nature. 1990; 343(6256):341-6. DOI: 10.1038/343341a0. View